MLTX
Price
$41.97
Change
-$0.66 (-1.55%)
Updated
May 9, 6:59 PM EST
90 days until earnings call
PHVS
Price
$20.57
Change
-$0.28 (-1.34%)
Updated
May 9, 6:59 PM EST
77 days until earnings call
Ad is loading...

MLTX vs PHVS

Header iconMLTX vs PHVS Comparison
Open Charts MLTX vs PHVSBanner chart's image
MoonLake Immunotherapeutics
Price$41.97
Change-$0.66 (-1.55%)
Volume$68.25K
CapitalizationN/A
Pharvaris
Price$20.57
Change-$0.28 (-1.34%)
Volume$6.71K
CapitalizationN/A
View a ticker or compare two or three
MLTX vs PHVS Comparison Chart

Loading...

MLTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PHVSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MLTX vs. PHVS commentary
May 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a StrongBuy and PHVS is a StrongBuy.

COMPARISON
Comparison
May 10, 2024
Stock price -- (MLTX: $41.97 vs. PHVS: $20.57)
Brand notoriety: MLTX and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 33% vs. PHVS: 33%
Market capitalization -- MLTX: $2.64B vs. PHVS: $1.12B
MLTX [@Biotechnology] is valued at $2.64B. PHVS’s [@Biotechnology] market capitalization is $1.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, PHVS is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 2 TA indicator(s) are bullish while PHVS’s TA Score has 4 bullish TA indicator(s).

  • MLTX’s TA Score: 2 bullish, 6 bearish.
  • PHVS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -1.41% price change this week, while PHVS (@Biotechnology) price change was -12.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.16%. For the same industry, the average monthly price growth was -4.80%, and the average quarterly price growth was +70.58%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 08, 2024.

PHVS is expected to report earnings on Jul 26, 2024.

Industries' Descriptions

@Biotechnology (+0.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MLTX with price predictions.
OPEN
A.I.dvisor published
a Summary for PHVS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MLTX($2.64B) has a higher market cap than PHVS($1.12B). PHVS YTD gains are higher at: -26.667 vs. MLTX (-30.502).
MLTXPHVSMLTX / PHVS
Capitalization2.64B1.12B235%
EBITDAN/AN/A-
Gain YTD-30.502-26.667114%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
MLTXPHVS
RSI
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
36%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
MLTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PHVSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VYCCX23.290.14
+0.60%
Voya Corporate Leaders 100 I
DLCEX23.740.10
+0.42%
Dana Large Cap Equity Investor
TCINX2.510.01
+0.40%
Templeton Global Balanced C1
OLGAX67.02N/A
N/A
JPMorgan Large Cap Growth A
LCBSX45.74N/A
N/A
ClearBridge Select FI

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with SYRE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-1.55%
SYRE - MLTX
41%
Loosely correlated
+6.57%
BCYC - MLTX
39%
Loosely correlated
-0.25%
ORIC - MLTX
32%
Poorly correlated
-0.94%
BNTC - MLTX
31%
Poorly correlated
+5.90%
PHVS - MLTX
30%
Poorly correlated
-1.34%
More

PHVS and

Correlation & Price change

A.I.dvisor tells us that PHVS and MLTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHVS and MLTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-1.34%
MLTX - PHVS
30%
Poorly correlated
-1.55%
CELC - PHVS
30%
Poorly correlated
-1.53%
AVTE - PHVS
26%
Poorly correlated
+1.71%
MRNS - PHVS
25%
Poorly correlated
-3.15%
APLMW - PHVS
24%
Poorly correlated
N/A
More